These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31213779)

  • 1. Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system.
    Cutler RL; Torres-Robles A; Wiecek E; Drake B; Van der Linden N; Benrimoj SIC; Garcia-Cardenas V
    Patient Prefer Adherence; 2019; 13():853-862. PubMed ID: 31213779
    [No Abstract]   [Full Text] [Related]  

  • 2. Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy.
    Torres-Robles A; Wiecek E; Cutler R; Drake B; Benrimoj SI; Fernandez-Llimos F; Garcia-Cardenas V
    Front Pharmacol; 2019; 10():130. PubMed ID: 30863308
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial.
    Davis E; Marra C; Gamble JM; Farrell J; Lockyer J; FitzGerald JM; Abu-Ashour W; Gillis C; Hawboldt J
    Trials; 2016 Oct; 17(1):502. PubMed ID: 27737686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs.
    Pringle JL; Boyer A; Conklin MH; McCullough JW; Aldridge A
    Health Aff (Millwood); 2014 Aug; 33(8):1444-52. PubMed ID: 25092847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Pharmacy and Registry Data Strengthens Clinical Assessments of Patient Adherence.
    Serhal S; Armour C; Billot L; Krass I; Emmerton L; Saini B; Bosnic-Anticevich S; Bereznicki B; Bereznicki L; Shan S; Campain A
    Front Pharmacol; 2022; 13():869162. PubMed ID: 35401235
    [No Abstract]   [Full Text] [Related]  

  • 11. The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies.
    Bosmans JE; van der Laan DM; Yang Y; Elders PJM; Boons CCLM; Nijpels G; Hugtenburg JG
    Front Pharmacol; 2019; 10():210. PubMed ID: 30899223
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications.
    Stanton-Robinson C; Al-Jumaili AA; Jackson A; Catney C; Veach S; Witry MJ
    J Am Pharm Assoc (2003); 2018; 58(4S):S120-S124. PubMed ID: 29891173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a patient-centered pharmacy program and intervention in a high-risk group.
    Moore JM; Shartle D; Faudskar L; Matlin OS; Brennan TA
    J Manag Care Pharm; 2013 Apr; 19(3):228-36. PubMed ID: 23537457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of medication non-adherence by disease groups: a systematic review.
    Cutler RL; Fernandez-Llimos F; Frommer M; Benrimoj C; Garcia-Cardenas V
    BMJ Open; 2018 Jan; 8(1):e016982. PubMed ID: 29358417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications.
    Yeung DL; Alvarez KS; Quinones ME; Clark CA; Oliver GH; Alvarez CA; Jaiyeola AO
    J Am Pharm Assoc (2003); 2017; 57(1):30-37. PubMed ID: 27816544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
    Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ
    Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
    Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
    JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.